The Immunology of Diabetes Society (IDS) is an international scientific society dedicated to advancing the understanding, prevention, and treatment of type 1 diabetes. Through its Congress, held every 18 months, IDS brings together researchers and clinicians from around the world to share groundbreaking discoveries, explore emerging therapies, and foster scientific collaboration. By connecting research on autoimmunity, beta-cell destruction, disease prediction, environmental triggers, and clinical trials, IDS works to accelerate progress toward more effective treatments and improved outcomes for people living with type 1 diabetes.

